News

The research program will combine Debiopharm’s AbYlink conjugation technology with Alkyon’s modular antibody platform and ...
TekniPlex Healthcare has commenced production activities at its new 200,000-square-foot facility in Madison, Wisconsin.
Nuvation Bio Inc., a global oncology company, received U.S. Food and Drug Administration (FDA) approval of Ibtrozi ...
Cryoport Inc. has completed the previously announced divestiture of its specialty courier business, CRYOPDP, to DHL Group.
BioNTech has agreed to acquire CureVac, a clinical-stage biotech company developing a novel class of transformative medicines.
OncoACP3 is a small molecule ligand with high affinity and specificity for Acid Phosphatase 3 (ACP3), a novel target in ...
Novo Nordisk and Deep Apple Therapeutics Inc. have entered a research collaboration and exclusive license agreement.
Schreiner MediPharm, a global provider of functional label solutions for the healthcare industry, has introduced the Smart ...
PL BioScience GmbH, a German life science company, has appointed Oliver Dick, PhD, as Chief Technology Officer.
The ExPERT and IRO platforms were integrated to improve the yield of gene-edited T cells and shorten manufacturing timelines.
Great Point Partners (GPP), a private investment firm focused on the health care industry, has acquired a majority stake in ...
Simtra BioPharma Solutions, a CDMO specializing in sterile injectables, has formed a five-year strategic alliance with the ...